Navigation Links
Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
Date:11/26/2013

Toronto, Canada (PRWEB) November 26, 2013

Pharmacovigilance Benefit-risk assessments are typically conducted as part of a regulatory inquiry, for completing the PBRER, the RMP, or as part of an NDA submission. However, benefit-risk assessments are also a crucial part of signal validation and due diligence for making portfolio decisions. This webinar will outline the methodology and conduct of safety benefit-risk assessments for post-marketed products.

There are currently several challenges for companies trying to meet the requirements for benefit-risk assessments. The methodology for identifying and calculating risks and their frequencies in the post-marketing phase is subject to different, varying factors and fraught with caveats. At the end of the day, measuring and defining benefit-risk for a specific product is subjective.

This webinar will look at the challenges of conducting benefit-risk assessments at both the portfolio and the product-level to:

  • Provide an overview of regulations in the EU and the US requiring benefit-risk assessments
  • Determine how to increase transparency with agencies and other stakeholders and discuss why transparency is important
  • Examine the consequences of incorrectly assessing benefit and risk

Join keynote speaker Mary Mease, Senior Director of Risk Management at Quintiles, to learn:

  • General guidelines for conducting benefit-risk assessments
  • Understand regulatory requirements around benefit-risk assessments

Mary Mease leads the Safety Knowledge Team, the business strategy for Lifecycle Safety, and the development of strategies and solutions for Risk Evaluation and Mitigation Strategies (REMS) at Quintiles.

For more information on this webinar or to register, visit:

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. PRA Expert to Present at Pharmacovigilance Conference
2. How to Ensure Pharmacovigilance Practices are Compliant with Global Safety Requirements: Challenges in Asia-Pacific
3. New Life Science Webinar Hosted by Xtalks Examines Outsourcing in Pharmacovigilance
4. Pharmacovigilance: ADR Management and Reporting & Outsourcing Trends, A New Drug Safety Webinar from Xtalks
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
6. Leaders in Science Join Upcoming Celebration of the 100th Anniversary of the Oldest Science Foundation in America
7. Cardium to Present at Upcoming Investor Conferences
8. Life Technologies to Present at Upcoming Investment Conferences in February
9. Cepheid to Webcast Upcoming Financial Presentations
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. Orexigen Therapeutics to Present at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... California (PRWEB) October 01, 2014 ... the National Science Foundation to expand their bioCAD/CAM software ... build and modify DNA. The Small Business Innovation Research ... the “j5” technology under exclusive license from the Lawrence ... Joint BioEnergy Institute , an LBNL laboratory that develops ...
(Date:10/1/2014)... PHILADELPHIA , October 1, 2014 ... plans to software invited to engage around the theme, ... 29-30     Elsevier ... information products and services, will host a gathering of ... discuss issues and trends impacting healthcare today and in ...
(Date:9/30/2014)... This news release is available in German . ... at the Technische Universitt Mnchen (TUM) have demonstrated a ... Their experiments show that future computer chips could be ... transistors. As the main enabling technology of the semiconductor ... fundamental limits, the TUM researchers and collaborators at the ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... trends and segments with highest potential revenues Do ... Visiongain,s updated report gives you revenue predictions for ... ahead. For those therapies you find financial data, ... new analysis you get sales forecasts to 2024 ...
Breaking Biology Technology:TeselaGen Receives $750k NSF SBIR Phase II Award 2TeselaGen Receives $750k NSF SBIR Phase II Award 3Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3A new dimension for integrated circuits: 3-D nanomagnetic logic 2A new dimension for integrated circuits: 3-D nanomagnetic logic 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5
... THOR ), a world leader in products ... healthcare,executive Steven H. Collis to its board of ... Thoratec board to nine directors. Collis, who ... is,executive vice president of AmerisourceBergen Corporation, and president ...
... Kline Report on Smart Coatings Cites Immediate Opportunities in ... Coatings, Cool Paint, and Smart Glass -, LITTLE ... and Medicaid that they will no longer reimburse expenses ... the paint and coatings industries to sell antimicrobial coatings,according ...
... New Era of Adaptive CT ... ... Solutions, (http://www.usa.siemens.com/medical ) has expanded the SOMATOM Definition(TM),family of computed tomography ... most challenging clinical situations. The SOMATOM,Definition family consists of the SOMATOM ...
Cached Biology Technology:Thoratec Announces Appointment of Steven H. Collis to Board of Directors 2Thoratec Announces Appointment of Steven H. Collis to Board of Directors 3Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S. 2Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 2Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 3Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 4Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner 5
(Date:9/30/2014)... FRANKFURT. Truffles, along ... world. Because they grow underground, people use trained dogs or ... is not only of interest to gourmets. A group of ... University Frankfurt have discovered that the smell of white truffles ... truffle fruiting bodies. , White truffles from the Piedmont region ...
(Date:9/30/2014)... Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich report that ... cells more sensitive to chemotherapeutic drugs. They have ... a new target for anti-tumor agents. , ... Professor Stephan Sieber of the Technische Universitt Mnchen ... a potential new weapon in the fight against ...
(Date:9/30/2014)... news release is available in German . ... in their behavioural response to risky situations such as ... for Ornithology now found in a long-term study on ... with both metabolic rate and ambient temperature. High metabolic ... behaviour, as in these scenarios birds were more likely ...
Breaking Biology News(10 mins):On the trail of the truffle flavor 2Cancer therapy: Driving cancer cells to suicide 2Risky metabolism 2
... the University of Bonn, working in collaboration with scientists ... previously unknown regulatory mechanism in the process of bone ... the treatment of osteoporosis. More than four million people, ... illness in Germany alone. In recognition of the importance ...
... L-arginine following a heart attack does not improve certain ... an increased risk of death, according to a study ... is a widely available dietary supplement and is publicized ... failure and sexual dysfunction, according to background information in ...
... The discovery of a possible hibernation hormone in the ... researchers reported in the April 7, 2006 issue of ... survive unscathed--in a state of suspended animation--under the harshest ... are confirmed, the hormone would represent the first essential ...
Cached Biology News:New weapon in battle against osteoporosis 2New weapon in battle against osteoporosis 3An elephant tail 2Possible brain hormone may unlock mystery of hibernation 2Possible brain hormone may unlock mystery of hibernation 3
... Clone/PAD: ZMD.467. Immunogen: Synthetic ... of the human rat mouse dog ... Specific for the human occludin protein. ... cell lysates). Reactivity with rat ...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....
Biology Products: